SAN FRANCISCO, June 14, 2023. Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with Nielsen BioSciences, Inc. (Nielsen), a privately-held biopharmaceutical company based in San Diego, CA, to study the safety and efficacy of CANDIN for the treatment of common warts. Nielsen focuses on developing…Read More
Vial Partners with Nielsen BioSciences Inc in Phase III Clinical Trial for the Treatment of Common Warts Drugscom MedNews
